Literature DB >> 31785387

Repeated application of photodynamic and antibiotic therapy as an adjunct to root surface debridement in patients with grade C and stage III or IV aggressive periodontitis.

Abdulaziz Abdullah Al-Khureif1, Badreldin A Mohamed2, Adel Zia Siddiqui3, Aftab Ahmed Khan4, Darshan Devang Divakar4.   

Abstract

PURPOSE: To evaluate the efficacy of antimicrobial photodynamic therapy (aPDT) and antimicrobial therapy on clinical and immunological outcomes of periodontal treatment in patients with periodontitis grade C and stage III or IV. MATERIAL AND
METHOD: The patients recruited in the current research fulfil the clinical case definition of periodontitis 'grade C' in terms of onset of the infection and stage III or IV that defines degree and severity of the disease. One-stage full-mouth ultrasonic debridement (UD) was performed and randomly divided in two groups: Group-I - four applications of aPDT, and Group-II - combination of metronidazole (MTZ) and amoxicillin (AMX) 3 tablets each for 7 days. Whole-mouth periodontal parameters were recorded at baseline, 3-, 6-months after completion of treatment. Gingival crevicular fluid samples were obtained for assessment of inflammatory interleukin (IL)-10 and IL-17 at the same time points.
RESULTS: Seventeen healthy patients completed the study protocol and revealed similar clinical findings at baseline. Bleeding scores significantly reduced in group-I at 3 months post treatment (p < 0.05). It could be seen that group-I showed statistically significant reduction of deep periodontal pockets and gain in CAL in patients with GAP at 3 months (p < 0.05). This difference was maintained at 6 months of follow-up (p < 0.001). Group-II was capable of increasing the levels of IL-10 and reducing IL-17 in GCF at both time periods compared to Group-I (p < 0.05). Group-I did not have significant effect on either cytokine levels in GCF (p > 0.05).
CONCLUSION: Antimicrobial photodynamic therapy improved severe deep periodontal pockets. However, the combination of antimicrobial therapy helped in reducing proinflammation in grade C and stage III or IV periodontitis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial photodynamic therapy; Interleukin; Periodontal therapy; Periodontitis; Photodynamic therapy

Mesh:

Substances:

Year:  2019        PMID: 31785387     DOI: 10.1016/j.pdpdt.2019.101610

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  1 in total

1.  Discrepancies in Antimicrobial Susceptibility between the JP2 and the Non-JP2 Genotype of Aggregatibacter actinomycetemcomitans.

Authors:  Margareta Granlund; Carola Höglund Åberg; Anders Johansson; Rolf Claesson
Journal:  Antibiotics (Basel)       Date:  2022-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.